143 related articles for article (PubMed ID: 26275380)
1. Biglycan enhances the ability of migration and invasion in endometrial cancer.
Sun H; Wang X; Zhang Y; Che X; Liu Z; Zhang L; Qiu C; Lv Q; Jiang J
Arch Gynecol Obstet; 2016 Feb; 293(2):429-38. PubMed ID: 26275380
[TBL] [Abstract][Full Text] [Related]
2. Lentivirus-mediated RNA interference targeting the long noncoding RNA HOTAIR inhibits proliferation and invasion of endometrial carcinoma cells in vitro and in vivo.
Huang J; Ke P; Guo L; Wang W; Tan H; Liang Y; Yao S
Int J Gynecol Cancer; 2014 May; 24(4):635-42. PubMed ID: 24758900
[TBL] [Abstract][Full Text] [Related]
3. [Effects of PPARγ gene expression on cell migration, invasion, and proliferation in endometrial cancer cells].
Xinxin H; Meng Z; Guiyu Z
Zhonghua Fu Chan Ke Za Zhi; 2014 May; 49(5):360-5. PubMed ID: 25030733
[TBL] [Abstract][Full Text] [Related]
4. Biglycan enhances gastric cancer invasion by activating FAK signaling pathway.
Hu L; Duan YT; Li JF; Su LP; Yan M; Zhu ZG; Liu BY; Yang QM
Oncotarget; 2014 Apr; 5(7):1885-96. PubMed ID: 24681892
[TBL] [Abstract][Full Text] [Related]
5. Expression of Biglycan in First Trimester Chorionic Villous Sampling Placental Samples and Altered Function in Telomerase-Immortalized Microvascular Endothelial Cells.
Chui A; Gunatillake T; Brennecke SP; Ignjatovic V; Monagle PT; Whitelock JM; van Zanten DE; Eijsink J; Wang Y; Deane J; Borg AJ; Stevenson J; Erwich JJ; Said JM; Murthi P
Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1168-1179. PubMed ID: 28408374
[TBL] [Abstract][Full Text] [Related]
6. Expression and significance of biglycan in endometrial cancer.
Liu Y; Li W; Li X; Tai Y; Lü Q; Yang N; Jiang J
Arch Gynecol Obstet; 2014 Mar; 289(3):649-55. PubMed ID: 24013431
[TBL] [Abstract][Full Text] [Related]
7. HER-2/neu-mediated down-regulation of biglycan associated with altered growth properties.
Recktenwald CV; Leisz S; Steven A; Mimura K; Müller A; Wulfänger J; Kiessling R; Seliger B
J Biol Chem; 2012 Jul; 287(29):24320-9. PubMed ID: 22582394
[TBL] [Abstract][Full Text] [Related]
8. The H3K9 Methyltransferase G9a Represses E-cadherin and is Associated with Myometrial Invasion in Endometrial Cancer.
Hsiao SM; Chen MW; Chen CA; Chien MH; Hua KT; Hsiao M; Kuo ML; Wei LH
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1556-65. PubMed ID: 25613390
[TBL] [Abstract][Full Text] [Related]
9. Biglycan potentially regulates angiogenesis during fracture repair by altering expression and function of endostatin.
Myren M; Kirby DJ; Noonan ML; Maeda A; Owens RT; Ricard-Blum S; Kram V; Kilts TM; Young MF
Matrix Biol; 2016; 52-54():141-150. PubMed ID: 27072616
[TBL] [Abstract][Full Text] [Related]
10. Up-regulation of Biglycan is Associated with Poor Prognosis and PTEN Deletion in Patients with Prostate Cancer.
Jacobsen F; Kraft J; Schroeder C; Hube-Magg C; Kluth M; Lang DS; Simon R; Sauter G; Izbicki JR; Clauditz TS; Luebke AM; Hinsch A; Wilczak W; Wittmer C; Büscheck F; Höflmayer D; Minner S; Tsourlakis MC; Huland H; Graefen M; Budäus L; Thederan I; Salomon G; Schlomm T; Melling N
Neoplasia; 2017 Sep; 19(9):707-715. PubMed ID: 28830008
[TBL] [Abstract][Full Text] [Related]
11. Activin B induces human endometrial cancer cell adhesion, migration and invasion by up-regulating integrin β3 via SMAD2/3 signaling.
Xiong S; Klausen C; Cheng JC; Zhu H; Leung PC
Oncotarget; 2015 Oct; 6(31):31659-73. PubMed ID: 26384307
[TBL] [Abstract][Full Text] [Related]
12. ETV5 transcription program links BDNF and promotion of EMT at invasive front of endometrial carcinomas.
Alonso-Alconada L; Eritja N; Muinelo-Romay L; Barbazan J; Lopez-Lopez R; Matias-Guiu X; Gil-Moreno A; Dolcet X; Abal M
Carcinogenesis; 2014 Dec; 35(12):2679-86. PubMed ID: 25233929
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of long noncoding RNA, NEAT1 promotes cell proliferation, invasion and migration in endometrial endometrioid adenocarcinoma.
Li Z; Wei D; Yang C; Sun H; Lu T; Kuang D
Biomed Pharmacother; 2016 Dec; 84():244-251. PubMed ID: 27664948
[TBL] [Abstract][Full Text] [Related]
14. [microRNA-140 suppresses the migration and invasion of colorectal cancer cells through targeting Smad3].
Zhao W; Zou J; Wang B; Fan P; Mao J; Li J; Liu H; Xiao J; Ma W; Wang M; Li L; Song B
Zhonghua Zhong Liu Za Zhi; 2014 Oct; 36(10):739-45. PubMed ID: 25567303
[TBL] [Abstract][Full Text] [Related]
15. Silencing of UCA1, a poor prognostic factor, inhibited the migration of endometrial cancer cell.
Lu L; Shen Y; Tseng KF; Liu W; Duan H; Meng W
Cancer Biomark; 2016 Jun; 17(2):171-7. PubMed ID: 27540975
[TBL] [Abstract][Full Text] [Related]
16. The effects of microRNA-183 promots cell proliferation and invasion by targeting MMP-9 in endometrial cancer.
Ruan H; Liang X; Zhao W; Ma L; Zhao Y
Biomed Pharmacother; 2017 May; 89():812-818. PubMed ID: 28273643
[TBL] [Abstract][Full Text] [Related]
17. Silencing of ghrelin receptor expression inhibits endometrial cancer cell growth in vitro and in vivo.
Fung JN; Jeffery PL; Lee JD; Seim I; Roche D; Obermair A; Chopin LK; Chen C
Am J Physiol Endocrinol Metab; 2013 Jul; 305(2):E305-13. PubMed ID: 23736537
[TBL] [Abstract][Full Text] [Related]
18. [Preliminary investigation of the expression and functions of insulin receptor isoforms in endometrial carcinoma].
Zhang G; Li XP; Wang JL; Wei LH
Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):839-45. PubMed ID: 23302125
[TBL] [Abstract][Full Text] [Related]
19. Functional and clinicopathological analysis of loss of MKK4 expression in endometrial cancer.
Ishikawa M; Nakayama K; Rahman MT; Rahman M; Katagiri A; Iida K; Miyazaki K
Oncology; 2010; 79(3-4):238-46. PubMed ID: 21372598
[TBL] [Abstract][Full Text] [Related]
20. [Isolation, purification and characterization of endothelial cells from endometrial cancer and normal endometrial tissue].
Du XL; Sheng XG; Yan CX; Liu T; Lu CH; Wang C; Yu H; Li QS
Zhonghua Zhong Liu Za Zhi; 2012 Jun; 34(6):409-13. PubMed ID: 22967440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]